Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04006483 · ClinicalTrials.gov registry record
Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque
A clinical trial of Dental Plaque, sponsored by Procter and Gamble.
- Completed
- Registry status
- 2,359
- Enrollment target
- 1
- Study location
NCT04006483: Completed study of Dental Plaque, sponsored by Procter and Gamble.
NCT04006483 is a study of Dental Plaque that has completed, run by Procter and Gamble. The registered enrollment target is 2,359 participants, above the 389-participant average among 10 other Dental Plaque trials with a reported enrollment target (506% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04006483, a study of Dental Plaque, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- 2,359 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.
Primary Outcome
Change from baseline as measured by mean plaque score reduction from baseline (via Quigley-Hein, Turesky Modification Index or Rustogi Modification of the Navy Plaque index).
Conditions Studied
Interventions
- DRUG Stannous fluoride dentifrice
- DRUG Positive control dentifrice
- DRUG Negative control dentifrice
Study Locations (1)
Ohio
- Multiple P&G Investigation Clinical Sites - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,359 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2018-11-30 |
What the finished NCT04006483 record still lists
NCT04006483 is an observational study that tracks outcomes without assigning an intervention. Its 2,359 participants enrollment target places it among the larger protocols in the corpus, above the 389-participant average among 10 other Dental Plaque trials with a reported enrollment target (506% higher).
The record links to 1 condition, with Dental Plaque appearing as the primary indexed condition, and to 3 interventions - of which Stannous fluoride dentifrice is the first listed.
NCT04006483 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04006483 about?
NCT04006483 is a clinical study titled "Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque". The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.
What is the current status of trial NCT04006483?
This trial is currently completed. The enrollment target is 2,359 participants. The study started on 2018-01-08. Estimated completion is 2018-11-30.
What conditions does trial NCT04006483 study?
This clinical trial studies the following conditions: Dental Plaque.
What interventions are being tested in trial NCT04006483?
The interventions under investigation include: Stannous fluoride dentifrice (DRUG), Positive control dentifrice (DRUG), Negative control dentifrice (DRUG).
Who is sponsoring clinical trial NCT04006483?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04006483 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Plaque
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04006483's enrollment target sits among peer trials
2,359 2nd of 10 the highest of 10 other Dental Plaque trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dental Plaque trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation
RECRUITING · NA
-
A Clinical Study to Evaluate the Efficacy of a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation
COMPLETED · NA
-
Evaluating the Effect of Tooth Cleaning Devices on Oral Health
COMPLETED · NA
-
A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation
COMPLETED · NA
-
A Meta-analysis Comparing Toothbrushes on Plaque Removal and Gingival Health
COMPLETED
-
Study of the Composition of Dental Plaque
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00025935 · 2,350 participants
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
- NCT03099850 · 2,345 participants
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- NCT05868421 · 2,376 participants · NA
Veteran Social Support for Enhancing Use of Smoking Cessation Treatment
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI